KHKathryn L. Haas

Kathryn L. Haas

*This is an algorithmically generated author record based on publicly available information.

Kathryn L. Haas has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Flexible Framework for Course-Based Undergraduate Research Experiences

    by Kathryn L. Haas, Jennifer Fishovitz, Michael J. Drummond, William C. Pfalzgraff, LeeAnn M. Sager-Smith

    Course-based undergraduate research experiences (CUREs) broaden access to the high-impact practice of undergraduate research. Unfortunately, many faculty lack a clear roadmap for developing a CURE. To address this barrier, we present a series of modular activities, the CURE "Flexi-Framework", which guides faculty through the process of creating a CURE based on their own research. Within the framework, students progress through four phases of scientific research: (I) Obtaining, Evaluating, and Organizing Information; (II) Asking Questions and Planning Investigations; (III) Investigation, Data Analysis, and Iteration; and (IV) Justification and Communication through a written report and/or oral presentation. Each phase consists of assessable, workshop-style activities that can be adapted to different research topics while maintaining the CURE-defining elements of collaboration, discovery and relevance, and iteration. Over the past decade, the Flexi-Framework has been used to implement multiple upper-division CUREs across three institutions and several subdisciplines of chemistry. Assessment using the Classroom Undergraduate Research Experience Survey and the Laboratory Course Assessment Survey demonstrates student-reported gains and course design elements consistent with national CURE benchmarks. The CURE Flexi-Framework thus provides a validated, adaptable pathway for integrating research into coursework, lowering the barrier to adopting CUREs across institutional and disciplinary contexts.

  • Open Access

    A Flexible Framework for Course-Based Undergraduate Research Experiences in Advanced Chemistry Laboratory Courses

    by Kathryn L. Haas, Jennifer Fishovitz, Michael J. Drummond, William C. Pfalzgraff, LeeAnn M. Sager-Smith

    Course-based undergraduate research experiences (CUREs) broaden access to the high-impact practice of undergraduate research, but even faculty experienced in mentoring undergraduate researchers may lack a clear roadmap for translating that research into a course format, creating a barrier to adoption of the CURE pedagogy. To address this barrier, we present a flexible framework (Flexi-Framework) for integrating faculty research into upper-level laboratory coursework using a series of activities that guide students through four phases of scientific research: (I) Obtaining, Evaluating, and Organizing Information, (II) Asking Questions and Planning Investigations; (III) Investigation, Data Analysis, and Iteration; and (IV) Justification and Communication through a written report and/or oral presentation. The framework consists of assessable, workshop-style activities that can be adapted to different research topics while maintaining the CURE-defining elements of collaboration, discovery and relevance, and iteration. Over the past decade, the Flexi-Framework has been implemented in multiple upper-division chemistry CUREs across three institutions and several subdisciplines of chemistry. Assessment using the Classroom Undergraduate Research Experience (CURE) survey and the Laboratory Course Assessment Survey (LCAS) demonstrates student-reported gains and course elements consistent with national CURE benchmarks. The CURE Flexi-Framework thus provides a model for integrating faculty research into coursework, with the goal of lowering barriers to CURE development and adoption across institutional and disciplinary contexts.

  • Open Access

    A Flexible Framework for Course-Based Undergraduate Research Experiences in Advanced Chemistry Laboratory Courses

    by Kathryn L. Haas, Jennifer Fishovitz, Michael J. Drummond, William C. Pfalzgraff, LeeAnn M. Sager-Smith

    Course-based undergraduate research experiences (CUREs) broaden access to the high-impact practice of undergraduate research, but even faculty experienced in mentoring undergraduate researchers may lack a clear roadmap for translating that research into a course format, creating a barrier to adoption of the CURE pedagogy. To address this barrier, we present a flexible framework (Flexi-Framework) for integrating faculty research into upper-level laboratory coursework using a series of activities that guide students through four phases of scientific research: (I) Obtaining, Evaluating, and Organizing Information, (II) Asking Questions and Planning Investigations; (III) Investigation, Data Analysis, and Iteration; and (IV) Justification and Communication through a written report and/or oral presentation. The framework consists of assessable, workshop-style activities that can be adapted to different research topics while maintaining the CURE-defining elements of collaboration, discovery and relevance, and iteration. Over the past decade, the Flexi-Framework has been implemented in multiple upper-division chemistry CUREs across three institutions and several subdisciplines of chemistry. Assessment using the Classroom Undergraduate Research Experience (CURE) survey and the Laboratory Course Assessment Survey (LCAS) demonstrates student-reported gains and course elements consistent with national CURE benchmarks. The CURE Flexi-Framework thus provides a model for integrating faculty research into coursework, with the goal of lowering barriers to CURE development and adoption across institutional and disciplinary contexts.

  • Open Access

    Cu(I) and Cu(II) binding by hyperactive variants of the human CTR1 N-terminus: Insights from cellular and model peptide studies

    by Kaylee Ruth, Emily Post, Xiaobin Wu, Heejeong Kim, M. Jake Pushie, Maria Escobedo, Kristin Kuter, Jaekwon Lee, Kathryn L. Haas


  • Investigating Cu(I) binding to model peptides of N-terminal Aβ isoforms

    by Abigail Strausbaugh Hjelmstad, M. Jake Pushie, Kaylee Ruth, Maria Escobedo, Kristin Kuter, Kathryn L. Haas


  • How did STEM students respond to a cross-campus discussion forum about macroethics? An exploratory content analysis of students’ written reflections

    by Gwynneth Hurley, Kathleen K. Eggleson, Jessica Young, Catherine Vaerewyck, Rider Foley, Kathryn L. Haas, Anderson Sunda-Meya

  • Exploration of the Potential Role of Serum Albumin in the Delivery of Cu(I) to Ctr1

    by Natalie B. Schulte, M. Jake Pushie, Ana Martinez, Madison Sendzik, Maria Escobedo, Kristin Kuter, Kathryn L. Haas

    Human serum albumin (HSA) is the major copper (Cu) carrier in blood. The majority of previous studies that have investigated Cu interactions with HSA have focused primarily on the Cu(II) oxidation state. Yet, cellular Cu uptake by the human copper transport protein (Ctr1), a plasma membrane-embedded protein responsible for Cu uptake into cells, requires Cu(I). Recent in vitro work has determined that reducing agents, such as the ascorbate present in blood, are sufficient to reduce the Cu(II)HSA complex to form Cu(I)HSA and that Cu(I) is bound to HSA with pM affinity. The biological accessibility of Cu(I)HSA suggests that HSA-bound Cu(I) may be an unappreciated form of Cu cargo and a key player in extracellular Cu trafficking. To better understand Cu trafficking by HSA, we sought to investigate the exchange of Cu(I) from HSA to a model peptide of the Cu-binding ectodomain of Ctr1. In this study, we used X-ray absorption near-edge spectroscopy to show that Cu(I) becomes more highly coordinated as increasing amounts of the Ctr1-14 model peptide are added to a solution of Cu(I)HSA. Extended X-ray absorption fine structure (EXAFS) spectroscopy was used to further characterize the interaction of Cu(I)HSA with Ctr1-14 by determining the ligands coordinating Cu(I) and their bond lengths. The EXAFS data support that some Cu(I) likely undergoes complete transfer from HSA to Ctr1-14. This finding of HSA interacting with and releasing Cu(I) to an ectodomain model peptide of Ctr1 suggests a mechanism by which HSA delivers Cu(I) to cells under physiological conditions.


  • Exploration of the Potential Role for Aβ in Delivery of Extracellular Copper to Ctr1

    by Ewelina Stefaniak, M. Jake Pushie, Catherine Vaerewyck, David Corcelli, Chloe Griggs, Whitney Lewis, Emma Kelley, Noreen Maloney, Madison Sendzik, Wojciech Bal, et al.

    Amyloid beta (Aβ) peptides are notorious for their involvement in Alzheimer’s disease (AD), by virtue of their propensity to aggregate to form oligomers, fibrils, and eventually plaques in the brain. Nevertheless, they appear to be essential for correct neurophysiology on the synaptic level and may have additional functions including antimicrobial activity, sealing the blood–brain barrier, promotion of recovery from brain injury, and even tumor suppression. Aβ peptides are also avid copper chelators, and coincidentally copper is significantly dysregulated in the AD brain. Copper (Cu) is released in significant amounts during calcium signaling at the synaptic membrane. Aβ peptides may have a role in maintaining synaptic Cu homeostasis, including as a scavenger for redox-active Cu and as a chaperone for clearing Cu from the synaptic cleft. Here, we employed the Aβ1–16 and Aβ4–16 peptides as well-established non-aggregating models of major Aβ species in healthy and AD brains, and the Ctr1–14 peptide as a model for the extracellular domain of the human cellular copper transporter protein (Ctr1). With these model peptides and a number of spectroscopic techniques, we investigated whether the Cu complexes of Aβ peptides could provide Ctr1 with either Cu(II) or Cu(I). We found that Aβ1–16 fully and rapidly delivered Cu(II) to Ctr1–14 along the affinity gradient. Such delivery was only partial for the Aβ4–16/Ctr1–14 pair, in agreement with the higher complex stability for the former peptide. Moreover, the reaction was very slow and took ca. 40 h to reach equilibrium under the given experimental conditions. In either case of Cu(II) exchange, no intermediate (ternary) species were present in detectable amounts. In contrast, both Aβ species released Cu(I) to Ctr1–14 rapidly and in a quantitative fashion, but ternary intermediate species were detected in the analysis of XAS data. The results presented here are the first direct evidence of a Cu(I) and Cu(II) transfer between the human Ctr1 and Aβ model peptides. These results are discussed in terms of the fundamental difference between the peptides’ Cu(II) complexes (pleiotropic ensemble of open structures of Aβ1–16 vs the rigid closed-ring system of amino-terminal Cu/Ni binding Aβ4–16) and the similarity of their Cu(I) complexes (both anchored at the tandem His13/His14, bis-His motif). These results indicate that Cu(I) may be more feasible than Cu(II) as the cargo for copper clearance from the synaptic cleft by Aβ peptides and its delivery to Ctr1. The arguments in favor of Cu(I) include the fact that cellular Cu export and uptake proteins (ATPase7A/B and Ctr1, respectively) specifically transport Cu(I), the abundance of extracellular ascorbate reducing agent in the brain, and evidence of a potential associative (hand-off) mechanism of Cu(I) transfer that may mirror the mechanisms of intracellular Cu chaperone proteins.


  • Using N-Terminal Coordination of Cu(II) and Ni(II) to Isolate the Coordination Environment of Cu(I) and Cu(II) Bound to His13 and His14 in Amyloid-β(4–16)

    by M. Jake Pushie, Ewelina Stefaniak, Madison R. Sendzik, Dimosthenis Sokaras, Thomas Kroll, Kathryn L. Haas

    The amyloid-β (Aβ) peptide is a cleavage product of the amyloid precursor protein and has been implicated as a central player in Alzheimer’s disease. The N-terminal end of Aβ is variable, and different proportions of these variable-length Aβ peptides are present in healthy individuals and those with the disease. The N-terminally truncated form of Aβ starting at position 4 (Aβ4–x) has a His residue as the third amino acid (His6 using the formal Aβ numbering). The N-terminal sequence Xaa-Xaa-His is known as an amino terminal copper and nickel binding motif (ATCUN), which avidly binds Cu(II). This motif is not present in the commonly studied Aβ1–x peptides. In addition to the ATCUN site, Aβ4–x contains an additional metal binding site located at the tandem His residues (bis-His at His13 and 14) which is also found in other isoforms of Aβ. Using the ATCUN and bis-His motifs, the Aβ4–x peptide is capable of binding multiple metal ions simultaneously. We confirm that Cu(II) bound to this particular ATCUN site is redox silent, but the second Cu(II) site is redox active and can be readily reduced with ascorbate. We have employed surrogate metal ions to block copper coordination at the ATCUN or the tandem His site in order to isolate spectral features of the copper coordination environment for structural characterization using extended X-ray absorption fine structure (EXAFS) spectroscopy. This approach reveals that each copper coordination environment is independent in the Cu2Aβ4–x state. The identification of two functionally different copper binding environments within the Aβ4–x sequence may have important implications for this peptide in vivo.